Related Experiment Video

Updated: Mar 24, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.0K

The ABCD's of 5'-adenosine monophosphate-activated protein kinase and adrenoleukodystrophy

Ian Weidling1,2, Russell H Swerdlow1,2,3,4

  • 1University of Kansas Alzheimer's Disease Center, Kansas City, Kansas, USA.

Journal of Neurochemistry
|March 19, 2016
PubMed

Insights

This study shows reduced AMP-activated protein kinase alpha 1 (AMPKα1) in X-linked adrenoleukodystrophy (X-ALD). Researchers suggest boosting AMPKα1 activity may offer therapeutic benefits for X-ALD patients.

Area of Science:

  • Neurochemistry
  • Metabolic pathways
  • Genetic disorders

Background:

  • X-linked adrenoleukodystrophy (X-ALD) is a rare genetic disorder affecting the nervous system and adrenal glands.
  • AMP-activated protein kinase alpha 1 (AMPKα1) plays a crucial role in cellular energy homeostasis.
  • Previous research suggests a potential link between AMPKα1 dysfunction and X-ALD pathogenesis.

Discussion:

  • The editorial highlights findings by Singh and colleagues demonstrating reduced AMPKα1 levels in X-ALD.
  • This reduction implies a potential therapeutic target for managing the disease.
  • The study proposes strategies to enhance AMPKα1 activity as a treatment approach.

Key Insights:

  • AMPKα1 is significantly reduced in X-linked adrenoleukodystrophy.
  • Increasing AMPKα1 activity is proposed as a therapeutic strategy for X-ALD.
  • Metformin is indicated as a potential agent to modulate AMPKα1 and improve mitochondrial function in X-ALD.

Outlook:

  • Further investigation into AMPKα1 modulation could lead to novel X-ALD therapies.
  • Understanding the precise mechanisms of AMPKα1 regulation in X-ALD is essential.
  • Clinical trials evaluating AMPKα1 activators may be warranted for X-ALD treatment.

More Related Videos

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium08:46

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium

Published on: September 1, 2015

10.3K
A High-content Assay for Monitoring AMPA Receptor Trafficking10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

8.2K

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.2K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.9K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.5K